Morphometric analysis of the immunohistochemical expression of Clara cell 10-kDa protein and surfactant apoproteins A and B in the developing bronchi and bronchioles of human fetuses and neonates.
Morphometric analyses of the immunohistochemical expression of the Clara cell secretory 10-kDa protein (CC10) and surfactant apoproteins A and B (SP-A and -B) were carried out on the developing bronchi and bronchioles of human fetuses and neonates. We analysed the ratio of the number of CC10-positive cells per subepithelial length of the bronchial or bronchiolar basement membrane and found that both the bronchial and the bronchiolar population of CC10-positive cells was significantly higher than that of either SP-A or SP-B. In addition, CC10 was found to be distributed mainly in the bronchiole. CC10-positive cells began to be recognized in the late pseudoglandular phase (15 weeks of gestation) and thereafter gradually increased in the canalicular and terminal sac phases, which correspond to the active development period of the acini or peripheral airways. The earliest expression of SP-A was also noted at 15 weeks of gestation, but its positive epithelial cells were present mainly in the larger bronchi. Double immunohistochemical staining for CC10 and SP-A revealed that the CC10-positive cells lining both the bronchi and bronchioles were different from the SP-A-positive cells. This finding suggests that CC10-positive cells are functionally and developmentally heterogeneous in both fetal and neonatal lungs in humans.
Xu
P
P
First Department of Pathology, Faculty of Medicine, Kyushu University 60, Fukuoka, Japan.
Hashimoto
S
S
Miyazaki
H
H
Asabe
K
K
Shiraishi
S
S
Sueishi
K
K
D000818:Animals; D001485:Basement Membrane / Q000378:metabolism; D001980:Bronchi / Q000166:cytology / Q000196:embryology / Q000378:metabolism*; D002452:Cell Count; D004791:Enzyme Inhibitors / Q000378:metabolism*; D004847:Epithelial Cells / Q000378:metabolism; D005333:Fetus / Q000378:metabolism*; D005865:Gestational Age; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D011506:Proteins / Q000378:metabolism*; D011510:Proteolipids / Q000378:metabolism*; D037662:Pulmonary Surfactant-Associated Protein A; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000378:metabolism*; D011817:Rabbits; D014598:Uteroglobin
D004791:Enzyme Inhibitors; D006023:Glycoproteins; D011506:Proteins; D011510:Proteolipids; D037662:Pulmonary Surfactant-Associated Protein A; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants; C556389:SCGB1A1 protein, human; D014598:Uteroglobin; D010741:Phospholipases A